Your browser is no longer supported. Please, upgrade your browser.
BioDelivery Sciences International, Inc.
Index- P/E14.71 EPS (ttm)0.24 Insider Own0.40% Shs Outstand100.99M Perf Week5.33%
Market Cap337.24M Forward P/E6.29 EPS next Y0.57 Insider Trans202.40% Shs Float98.56M Perf Month2.59%
Income25.70M PEG0.59 EPS next Q0.06 Inst Own77.60% Short Float3.87% Perf Quarter-13.59%
Sales156.50M P/S2.15 EPS this Y233.10% Inst Trans5.13% Short Ratio3.41 Perf Half Y-4.81%
Book/sh1.08 P/B3.30 EPS next Y103.60% ROA- Target Price- Perf Year-18.91%
Cash/sh1.23 P/C2.90 EPS next 5Y25.00% ROE- 52W Range3.04 - 5.45 Perf YTD-15.24%
Dividend- P/FCF- EPS past 5Y18.50% ROI17.50% 52W High-34.68% Beta0.72
Dividend %- Quick Ratio3.10 Sales past 5Y26.50% Gross Margin84.20% 52W Low17.11% ATR0.17
Employees176 Current Ratio3.40 Sales Q/Q7.00% Oper. Margin25.70% RSI (14)54.46 Volatility5.88% 4.38%
OptionableYes Debt/Eq0.72 EPS Q/Q- Profit Margin- Rel Volume1.23 Prev Close3.18
ShortableYes LT Debt/Eq0.72 EarningsMay 06 BMO Payout0.00% Avg Volume1.12M Price3.56
Recom1.90 SMA205.36% SMA50-1.26% SMA200-10.12% Volume1,376,394 Change11.95%
Apr-22-20Initiated Northland Capital Outperform $9
Jan-09-20Initiated Piper Sandler Overweight $9
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
May-06-21 10:00PM  
Apr-29-21 05:00PM  
Apr-20-21 08:00AM  
Apr-09-21 11:30AM  
Mar-30-21 07:22AM  
Mar-22-21 01:33AM  
Mar-18-21 06:02PM  
Mar-10-21 03:30PM  
Mar-03-21 12:30PM  
Feb-17-21 08:00AM  
Feb-11-21 08:00AM  
Feb-08-21 10:11AM  
Feb-05-21 01:07AM  
Jan-15-21 09:00AM  
Dec-21-20 11:54PM  
Dec-19-20 06:11PM  
Dec-05-20 11:31AM  
Nov-20-20 08:30AM  
Nov-17-20 09:40AM  
Nov-11-20 08:30AM  
Nov-07-20 08:02AM  
Nov-06-20 06:00AM  
Nov-05-20 07:00PM  
Nov-04-20 05:31PM  
Oct-23-20 08:00AM  
Sep-28-20 10:41AM  
Sep-24-20 10:46AM  
Sep-14-20 12:06PM  
Sep-11-20 08:00AM  
Sep-04-20 11:31AM  
Sep-03-20 08:00AM  
Aug-10-20 09:08AM  
Aug-06-20 10:05AM  
Aug-05-20 09:05AM  
Jul-29-20 12:33PM  
Jul-27-20 04:01PM  
Jul-12-20 07:39PM  
Jun-10-20 05:44PM  
Jun-09-20 11:38PM  
Jun-06-20 11:31AM  
May-29-20 12:17PM  
May-26-20 10:43AM  
May-11-20 08:30AM  
May-09-20 05:01PM  
May-08-20 10:52AM  
May-07-20 06:35PM  
Apr-30-20 12:34PM  
Apr-28-20 08:00AM  
Apr-27-20 12:31PM  
Mar-24-20 10:02PM  
Mar-14-20 08:51AM  
Mar-13-20 09:29AM  
Mar-12-20 08:55PM  
Mar-09-20 08:00AM  
Mar-05-20 12:30PM  
Feb-27-20 05:15PM  
Feb-24-20 02:59PM  
Feb-20-20 08:00AM  
Feb-06-20 10:44AM  
Jan-30-20 10:15AM  
Jan-29-20 10:06AM  
Jan-27-20 05:20PM  
Jan-13-20 08:30AM  
Jan-08-20 12:00PM  
Jan-06-20 08:30AM  
Dec-30-19 09:44AM  
Dec-27-19 07:53PM  
Dec-25-19 12:00PM  
Dec-19-19 08:30AM  
Dec-12-19 11:30AM  
Dec-10-19 10:48AM  
Dec-06-19 12:00PM  
Dec-05-19 09:07AM  
Dec-04-19 11:05AM  
Dec-03-19 09:16AM  
Nov-29-19 09:13AM  
Nov-27-19 08:30AM  
Nov-25-19 08:30AM  
Nov-22-19 09:48AM  
Nov-20-19 10:00AM  
Nov-19-19 09:26AM  
Nov-14-19 10:20AM  
Nov-13-19 08:00AM  
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KOTLER KEVINDirectorMay 13Buy3.2550,000162,5004,655,689May 13 05:38 PM
Sirgo Mark ADirectorMay 13Buy3.163,0009,4801,106,595May 13 05:36 PM
KOTLER KEVINDirectorMay 12Buy3.24100,000324,0004,605,689May 13 05:38 PM
Sirgo Mark ADirectorMay 12Buy3.245,00016,2001,103,595May 13 05:36 PM
KOTLER KEVINDirectorMay 11Buy3.16150,000474,0004,505,689May 13 05:38 PM
Sirgo Mark ADirectorMay 11Buy3.167,50023,7001,098,595May 13 05:36 PM
Plesha Scott M.See RemarksMar 12Option Exercise0.0020,8340299,874Mar 16 04:57 PM
Bailey Jeffrey AllenChief Executive OfficerMar 09Option Exercise0.005,333040,900Mar 11 04:14 PM
Vollins JamesSee RemarksFeb 08Sale4.163,83315,9450Feb 08 05:46 PM
Vollins JamesSee RemarksFeb 04Sale3.978,30332,9633,833Feb 08 05:46 PM
Plesha Scott M.See RemarksFeb 01Option Exercise0.0013,3330258,206Feb 02 06:17 PM
Smith Thomas BChief Medical OfficerFeb 01Option Exercise0.007,667019,954Feb 02 05:55 PM
Vollins JamesSee RemarksFeb 01Option Exercise0.003,833012,136Feb 02 05:59 PM
Coelho Mary TheresaSee RemarksFeb 01Sale3.873,46013,39030,619Feb 02 07:12 PM
Coelho Mary TheresaSee RemarksJan 29Option Exercise0.0010,190034,079Feb 02 07:12 PM
Plesha Scott M.See RemarksJan 29Option Exercise0.0010,8700244,873Feb 02 06:17 PM
Smith Thomas BChief Medical OfficerJan 29Option Exercise0.007,548012,287Feb 02 05:55 PM
Vollins JamesSee RemarksJan 29Option Exercise0.008,30308,303Feb 02 05:59 PM
Coelho Mary TheresaSee RemarksJan 19Sale4.326,46227,91623,889Jan 20 04:30 PM
Coelho Mary TheresaSee RemarksJan 15Option Exercise0.0018,333030,351Jan 20 04:30 PM
Vollins JamesSee RemarksDec 16Option Exercise3.469,50532,8879,505Dec 16 04:39 PM
Vollins JamesSee RemarksDec 16Sale4.489,50542,5820Dec 16 04:39 PM
Bailey Jeffrey AllenChief Executive OfficerDec 15Sale4.3510,00043,50035,567Dec 16 04:41 PM
Vollins JamesSee RemarksDec 14Option Exercise3.4620,32070,30720,320Dec 16 04:39 PM
Vollins JamesSee RemarksDec 14Sale4.4620,32090,6270Dec 16 04:39 PM
Singh VanilaDirectorNov 23Option Exercise0.005,333012,084Nov 27 04:16 PM
Bailey Jeffrey AllenChief Executive OfficerNov 04Option Exercise0.0040,000045,567Nov 06 05:21 PM
Davis Todd CDirectorAug 18Sale4.9950,000249,500217,914Aug 20 04:16 PM
Watson W. MarkDirectorAug 17Sale5.1813,00067,34052,979Aug 19 04:30 PM
Sirgo Mark ADirectorAug 14Sale4.90115,000563,5001,091,095Aug 17 06:58 PM
Sirgo Mark ADirectorAug 13Sale4.5385,000385,0501,206,095Aug 17 06:58 PM
KOTLER KEVINDirectorAug 07Option Exercise0.9845,00043,9504,355,689Aug 11 05:16 PM
Greenleaf PeterDirectorAug 07Option Exercise0.0035,000059,788Aug 11 05:03 PM
Sirgo Mark ADirectorAug 07Option Exercise0.004,00001,291,095Aug 11 04:55 PM
Singh VanilaDirectorAug 07Option Exercise0.006,75106,751Aug 11 04:54 PM
Bailey Jeffrey AllenChief Executive OfficerAug 07Option Exercise0.005,56705,567Aug 11 04:53 PM
Watson W. MarkDirectorAug 07Option Exercise0.0030,000065,979Aug 11 04:51 PM
Davis Todd CDirectorAug 07Option Exercise0.0030,0000267,914Aug 11 04:50 PM
Vollins JamesSee RemarksMay 21Option Exercise3.9021,66684,49721,666May 22 04:04 PM
Vollins JamesSee RemarksMay 21Sale4.6021,66699,6640May 22 04:04 PM
Plesha Scott M.See RemarksMay 18Sale4.5215,00067,800234,003May 20 04:38 PM